Author [ Title] Type Year
Filters: Author is Kröger, Nicolaus [Clear All Filters]
5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.Mediators Inflamm2014, 418292.(2014).
Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors - A retrospective study by the EBMT Chronic Malignancies Working Party.Biol Blood Marrow Transplant.(2019).
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL-mutation.Eur J Haematol.(2019).
Allogeneic stem-cell transplantation with sequential conditioning in adult patients with refractory or relapsed acute lymphoblastic leukemia: a report from the EBMT Acute Leukemia Working Party.Bone Marrow Transplant.(2019).
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.N Engl J Med374, 43-53.(2016).
Assessment of Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis.Biol Blood Marrow Transplant.(2019).
B cell maturation antigen-specific CAR T cells for relapsed or refractory multiple myeloma: a meta-analysis.Eur J Haematol.(2019).
Cancer-and-treatment-specific distress and its impact on post-traumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT).Psychooncology.(2016).
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT.Haematologica.(2014).
Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis.Proc Natl Acad Sci U S A.(2014).
HLA mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis.Biol Blood Marrow Transplant.(2018).
Induction, bridging or straight ahead the ongoing dilemma of allografting in advanced MDS.Biol Blood Marrow Transplant.(2019).
Outcome after transplantation according to reduced intensity conditioning regimen in patients transplanted for myelofibrosis.Biol Blood Marrow Transplant.(2016).
OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.Biol Blood Marrow Transplant.(2019).
Possible Role of Minor H Antigens in the Persistence of Donor Chimerism after Stem Cell Transplantation; Relevance for Sustained Leukemia Remission.Plos One10, e0119595.(2015).